← Back to Search

Cervical Retraction Device for Post-Procedural Pain

N/A
Waitlist Available
Led By David Turok, MD, MPH
Research Sponsored by Bioceptive
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects presenting for IUD insertion or endometrial biopsy
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will test a suction-based method of engaging the cervix, which may diminish pain and discomfort.

Who is the study for?
This trial is for women who can consent in English or Spanish and are undergoing an IUD insertion or endometrial biopsy. It's not open to pregnant women, those with cervical abnormalities, post-menopausal women, or anyone who has used narcotics or benzodiazepines before the procedure.Check my eligibility
What is being tested?
The study tests a new device by Bioceptive that attaches gently to the cervix during gynecologic procedures like IUD insertions and biopsies. The aim is to see if this suction-based method reduces pain compared to traditional methods.See study design
What are the potential side effects?
Since it's a minimal risk device designed to be gentle and non-traumatic, side effects may be less than current methods but could include discomfort at the attachment site or minor bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am going for an IUD insertion or endometrial biopsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Intensity Measure 100 point visual analogue scale
Secondary outcome measures
Procedural Satisfaction Patient records level of satisfaction with the procedure (Very Unsatisfied, Unsatisfied, Neutral, Satisfied, Very Satisfied)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Bioceptive Cervical Retraction DeviceExperimental Treatment2 Interventions
Suction based method for stabilizing the cervix and uterus. Achieves suction 360 degrees around cervical os creating a portal through which instruments can be passed into the cervical canal and uterus. Provider can still place traction on uterus with this device just as with tenaculum.
Group II: Standard Cervical TenaculumActive Control2 Interventions
Single tooth tenaculum, pierces the tissue of the cervix to allow provider to stabilize and place traction on the cervical cal/uterus
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Endometrial biopsy
2013
Completed Phase 3
~960

Find a Location

Who is running the clinical trial?

BioceptiveLead Sponsor
David Turok, MD, MPHPrincipal InvestigatorUniversity of Utah, Dept. of Obstetrics and Gynecology
4 Previous Clinical Trials
3,073 Total Patients Enrolled

Media Library

Novel Cervical Retraction Device Clinical Trial Eligibility Overview. Trial Name: NCT02283463 — N/A
Post-Procedural Pain Research Study Groups: Standard Cervical Tenaculum, Bioceptive Cervical Retraction Device
Post-Procedural Pain Clinical Trial 2023: Novel Cervical Retraction Device Highlights & Side Effects. Trial Name: NCT02283463 — N/A
Novel Cervical Retraction Device 2023 Treatment Timeline for Medical Study. Trial Name: NCT02283463 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria need to be fulfilled for individuals to participate in this research?

"Acceptance into this clinical trial necessitates that potential participants suffer from pain due to a particular procedure and are between 18-45 years old. Presently, the team is looking for 24 volunteers."

Answered by AI

Does the enrollment criteria for this medical trial encompass individuals younger than sixty years of age?

"The age range for eligibility is 18-45, as specified in the criteria for participant selection."

Answered by AI

Are there any eligibility requirements to join this research project?

"The clinicaltrials.gov page confirms that this trial is no longer recruiting patients, with the original listing being posted on September 1st 2014 and last updated July 18th 2017. However, there are currently other trials actively enrolling participants at the moment."

Answered by AI
~2 spots leftby Apr 2025